Skip to search formSkip to main contentSkip to account menu

Ziracin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

evernimicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Ziracin-Induced Congenital Urogenital Malformations in Female Rats
Spontaneous hypospadias is seldom observed in rats in contrast to its occurrence in 1 out of 250 human births. Ziracin, an… 
2002
2002
Isolation and characterization of novel oligosaccharides related to Ziracin.
Five novel oligosaccharide antibiotics, Sch 58769 (1), Sch 58771 (2), Sch 58773 (3), Sch 58775 (4), and Sch 58777 (5), were… 
2001
2001
Pharmacokinetics of a New Parenteral Oligosaccharide Antibiotic, SCH27899 (Ziracin), in Healthy Subjects
ABSTRACT The pharmacokinetic properties of an everninomicin antibiotic (SCH27899; Ziracin) were studied with healthy Japanese… 
2000
2000
In Vivo Activity and Pharmacokinetics of Ziracin (SCH27899), a New Long-Acting Everninomicin Antibiotic, in a Murine Model of Penicillin-Susceptible or Penicillin-Resistant Pneumococcal Pneumonia
ABSTRACT The effectiveness of ziracin (SCH27899), a novel everninomicin, was at first investigated against lethal pneumonia… 
Review
1999
Review
1999
Pharmacologic and Bacteriologic Properties of SCH‐27899 (Ziracin), an Investigational Antibiotic from the Everninomicin Family
SCH‐27899 is an investigational antibiotic from the everninomicin family, a group of oligosaccharide antibiotics produced by… 
1999
1999
Total Synthesis of Everninomicin 13,384-1-Part 2: Synthesis of the FGHA(2) Fragment.
The powerful antibiotic everninomicin 13,384-1 (1, Ziracin) has been prepared for the first time through a total synthesis. The 1… 
1999
1999
Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality…
SCH27899 is an oligosaccharide, everninomicin antibiotic with activity primarily against Gram-positive pathogens. The activity of… 
1999
1999
Chemical modifications and structure activity studies of ziracin and related everninomicin antibiotics.
1999
1999
In vitro activity of SCH 27899 (Ziracin) against Legionella species.
1999
1999
Structural Elucidation of Ziracin, a Novel Antibiotic which is Active Against Organisms Resistant to Methicillin and Vancomycin.
Ziracin 1 (1) is a member of the everninomicin 2 group of antibiotics and is highly active against Gram-positive bac teria… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)